From Quintiles: New research indicates that managed care executives, physicians and patients are not on the same page on a wide range of issues:
"A question about personalized medicine found that 88 percent of biophama executives and 84 percent of managed care respondents felt these new products will be effective. But 75 percent of patient respondents answered “no” when asked if they had heard of personalized medicine. Respondents also could not agree on what constitutes “value” in healthcare. About 38 percent of pharma executives said any definition of value must include both cost and outcomes, while just 2 percent of patients felt that way"(Thanks to MedCity News for the heads-up.)
Comments